Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Mangoceuticals, Inc. (MGRX) had Return on Investments of -135.82% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$0.46M |
|
$-20.64M |
|
$0.21M |
|
$0.25M |
|
$18.49M |
|
$-18.03M |
|
$-2.61M |
|
$-20.64M |
|
$-18.28M |
|
$-20.64M |
|
$-20.64M |
|
$-20.64M |
|
$-18.28M |
|
$-18.03M |
|
$-15.07M |
|
10.07M |
|
10.07M |
|
$-2.17 |
|
$-2.17 |
|
| Balance Sheet Financials | |
$1.55M |
|
$0.00M |
|
$14.54M |
|
$16.09M |
|
$0.89M |
|
-- |
|
-- |
|
$0.89M |
|
$15.20M |
|
$0.97M |
|
$15.20M |
|
15.89M |
|
| Cash Flow Statement Financials | |
$-5.85M |
|
$0.00M |
|
$7.27M |
|
$0.06M |
|
$1.49M |
|
$1.43M |
|
$10.72M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.74 |
|
-- |
|
-- |
|
-- |
|
-- |
|
54.91% |
|
-3954.28% |
|
-3954.28% |
|
-3304.28% |
|
-4526.86% |
|
-4526.76% |
|
$-5.85M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
-- |
|
-- |
|
-135.82% |
|
-2135.85% |
|
-128.30% |
|
|
Return on Investments |
-135.82% |
$0.96 |
|
$-0.58 |
|
$-0.58 |
|